NRX Pharmaceuticals, Inc. NRXP US Equity☆

NRX Pharmaceuticals, Inc. (Nasdaq: NRXP), an SEC filer in Pharmaceutical Preparations, closed at $3.55, -1.9%, on 2026-08-28, with a market cap of $238M as of 2026-08-27 and a net margin of -1980.8%. Institutional ownership, earnings history and filed financials are on the tabs below.